ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,464.62
0.00%
US Tech 100
19,141.20
-0.34%
다우존스 지수
39,150.33
0.00%
Bitcoin
61,099.00
-3.26%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Tango Therapeutics Inc (TNGX)

  7. Tango Therapeutics Inc (TNGX) 뉴스

TNGX Tango Therapeutics Inc

10.10
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Tango Therapeutics Inc TNGX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 10.10 20:00:00
개장가 저가 고가 종가 전일 종가
10.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/06/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/06/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/06/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/06/202405:06EDGAR2Form 8-K - Current report
05/06/202420:00BWTango Therapeutics to Present at the Goldman Sachs 45th..
23/05/202422:18PRNUSMedivir´s licensee, Tango Therapeutics, has discontinued..
23/05/202420:18EDGAR2Form 8-K - Current report
23/05/202420:00BWTango Therapeutics Announces Discontinuation of TNG348..
08/05/202420:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202420:14EDGAR2Form 8-K - Current report
08/05/202420:00BWTango Therapeutics Reports First Quarter 2024 Financial..
02/04/202405:48BWTango Therapeutics Announces Inducement Grants Under Nasdaq..
18/03/202420:00BWTango Therapeutics Reports Fourth Quarter and Full Year 2023..
06/03/202421:00BWTango Therapeutics to Participate in Upcoming Investor..
06/03/202406:47GLOBETango Therapeutics to Highlight Preclinical Data on..
09/02/202411:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202411:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202421:00EDGAR2Form 8-K - Current report
06/02/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202421:00GLOBETango Therapeutics to Present at the Guggenheim Healthcare..
06/01/202406:05GLOBETango Therapeutics Announces Inducement Grants Under Nasdaq..
04/01/202416:47PRNUSMedivir´s licensee, Tango Therapeutics, has dosed the first..
03/01/202421:00GLOBETango Therapeutics Announces First Patient Dosed in Phase..
13/11/202321:00GLOBETango Therapeutics to Highlight Preclinical Data on PRMT5..
08/11/202321:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202321:07EDGAR2Form 8-K - Current report
08/11/202321:00GLOBETango Therapeutics Reports Third Quarter 2023 Financial..
07/11/202321:00GLOBETango Therapeutics to Present at the Jefferies London..
03/11/202305:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202306:23EDGAR2Form SC 13D/A - General statement of acquisition of..
18/09/202320:00GLOBETango Therapeutics to Highlight Preclinical Data on..
12/09/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
06/09/202320:00GLOBETango Therapeutics Announces FDA Clearance of..
05/09/202320:00GLOBETango Therapeutics to Participate in the H.C. Wainwright..
01/09/202320:34EDGAR2Form S-3 - Registration statement under Securities Act of..
01/09/202305:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/09/202305:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/08/202319:04EDGAR2Form 8-K - Current report
30/08/202306:08GLOBETango Therapeutics Announces Updates to Its Board of..
28/08/202320:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
22/08/202305:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/08/202305:40EDGAR2Form SC 13D/A - General statement of acquisition of..
10/08/202320:24EDGAR2Form 8-K - Current report
10/08/202320:00GLOBETango Therapeutics Announces $80 million Private Placement..
07/08/202320:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202320:25EDGAR2Form 8-K - Current report
07/08/202320:00GLOBETango Therapeutics Reports Second Quarter 2023 Financial..
24/07/202320:00GLOBETango Therapeutics Announces First Patient Dosed in TNG260..

최근 히스토리

NASDAQ
TNGX
Tango Therapeutics
LSE
SM09
Tower B.f 64 S
LSE
LLOY
Lloyds Banking
LSE
BB72
Greek 4%1887
LSE
16ID
Metro.tokyo 25u
USOTC
DFORF
D4T4 Solutions (PK)
LSE
52AX
Bidvest 26 S
NASDAQ
CDNS
Cadence Design Systems
EU
FR2CIBFS0375
Credit Agricole CIB Fina...
LSE
CRPU
Is Gb Cp Bd Hdg
NASDAQ
VSAC
Vision Sensing Acquisition
NASDAQ
AAXCOXX
Bank of Montreal Autocal...
BOV
MILS3R
MILLS ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유